Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Equity: 2011-2025

Historic Return on Equity for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to 0.03%.

  • Aytu Biopharma's Return on Equity rose 18.00% to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year increase of 18.00%. This contributed to the annual value of 0.03% for FY2025, which is 13.00% up from last year.
  • Per Aytu Biopharma's latest filing, its Return on Equity stood at 0.03% for FY2025, which was up 126.80% from 0.10% recorded in FY2024.
  • Aytu Biopharma's Return on Equity's 5-year high stood at 0.03% during FY2025, with a 5-year trough of 1.20% in FY2022.
  • In the last 3 years, Aytu Biopharma's Return on Equity had a median value of 0.10% in 2024 and averaged 0.16%.
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by 69bps in 2022, then surged by 79bps in 2023.
  • Aytu Biopharma's Return on Equity (MRY) stood at 0.50% in 2021, then tumbled by 139bps to 1.20% in 2022, then soared by 66bps to 0.41% in 2023, then skyrocketed by 76bps to 0.10% in 2024, then soared by 127bps to 0.03% in 2025.
  • Its Return on Equity stands at 0.03% for FY2025, versus 0.10% for FY2024 and 0.41% for FY2023.